G6N-21518-13840
3 vaccinations
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 921 / CA
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- XSY-14007-91628
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-11
Dose 1 — Pfizer-BioNTech
-
2021-12-03
Dose 2 — Pfizer-BioNTech
-
2022-06-17
Dose 3 — Pfizer-BioNTech
-
2022-06-21
Registered in v-safe
- 2022-06-21
- 2022-06-22
- 2022-06-23
- 2022-06-24
- 2022-07-03
- 2022-07-08
- 2022-07-15
- 2022-07-24
- 2022-07-29
- 2022-09-16
-
2022-12-17
Survey response — 6 months, dose 3, dependentMedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2023-06-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-11 | Pfizer-BioNTech | No |
| 2 | 2021-12-03 | Pfizer-BioNTech | No |
| 3 | 2022-06-17 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: Runny nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release